Nina Onishchenko

Prof. Dr. Nina Onishchenko

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
ALAlexey Lyundup
Alexey Lyundup
MSMurat Shagidulin
Murat Shagidulin
NONina Onishchenko
Nina Onishchenko
VBValery Beregovykh
Valery Beregovykh
МКМиша Крашенинников
Миша Крашенинников
SGSergey Gautier
Sergey Gautier
Mesenchymal stem cells (MSCs) are known to assist liver regeneration. In this study, we show a dose-dependent mode of recovery from liver fibrosis after intravenous injections of MSCs. Male Wistar rats experienced a 42-day-long modeling of liver fibrosis via CCl4 poisoning and received either a single injection of 2.5 × 106 MSCs on Day 3 after the last CCl4 dose or two MSC injections on Days 3 and 10. We dynamically monitored levels of liver cytolysis markers and cytokines in the venous blood and performed a histological study of Mallory-stained liver sections. All experimental groups experienced a nearly complete recovery of biochemical markers up to 4 weeks after the end of CCl4 administration, although we observed anti-inflammatory changes in the cytokine levels only in animals treated by two MSC injections. Histological study revealed minor signs of liver damage up to Day 90 in animals receiving two MSC doses with worse pathology in those who received a single MSC dose. Morphometric values stayed consistent with visual data, demonstrating a significantly larger number of binuclear hepatocytes, a smaller number of false lobules, and a lesser area of connective tissue proper in animals treated by two MSC injections. Our results reflect MSC grafting in applied doses to affect liver fibrosis in a dose-dependent mode. These findings provide a deeper understanding of MSC action in liver fibrosis, and the doses applied may serve as a milestone for further studies in humans.

30 March 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
NONina Onishchenko
Nina Onishchenko
MSMurat Shagidulin
Murat Shagidulin
ZGZalina Gonikova
Zalina Gonikova
ANAlla Nikolskaya
Alla Nikolskaya
LKLudmila Kirsanova
Ludmila Kirsanova
SGSergey Gautier
Sergey Gautier
Hematopoietic stem cells derived from bone marrow are known to induce tissue repair. Their mechanisms to induce liver regeneration are not clear and may have numerous adverse effects. We compared the regenerative potential of intact hematopoietic stem cells (iHSCs), their total RNA, and apoptotic hematopoietic stem cells (aHSCs) in liver damage. Male Wistar rats (n = 40 per group) experienced a 75% liver resection and received single intraperitoneal injections of saline (control group), iHSCs, aHSCs, or total RNA of iHSCs. We recorded animal survival, liver mass, blood markers of liver cell lysis and function (albumin, aminotransferases, alkaline phosphatase), and liver histological features: mitotic index and expression of markers for proliferation and apoptosis (caspase-9, caspase-3, and Ki-67). We assessed the survival with the log-rank test and used Wilcoxon and t tests for the other parameters. Animals of all HSC- or RNA-treated groups survived until the end of the experiment with full blood marker recovery (p = 0.037). The liver mass enlarged mostly after apoptotic hematopoietic stem cells and total RNA. Mitotic index peaked in the group of total RNA with a lower but earlier increase for the aHSC group, and Ki-67 proliferation for the total RNA group was the highest (all the differences were significant with p values ˂ 0.05). We found the aHSCs and total RNA of iHSC group to be the most efficient for liver reparation. Total RNA from HSCs is preferred for further liver regeneration studies.

16 April 2024 in ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
Verified
Journal Article
Open access
PDF file
ОСОльга Ивановна Степанова
Ольга Ивановна Степанова
IAIrina Alchinova
Irina Alchinova
ACAnton Cherepov
Anton Cherepov
AMArkadiy A Metelkin
Arkadiy A Metelkin
MKMikhail Karganov
Mikhail Karganov
ЮБЮлия Борисовна Басок
Юлия Борисовна Басок
Цель работы: изучить динамику состояния клеток крови и костного мозга при прогрессирующем развитии сахарного диабета 2 типа (СД2) в зависимости от степени тяжести нарушений окислительно-восстановительных процессов (ОВП) в тканях организма. Методика. Использована генетическая модель СД2 у мутантных мышей – db/db (опытная группа n=30). Контролем слу жили здоровые мыши той же линии – db/+m (n=10) и линии B10 (n=5). В течение 6–6,5 мес контролировали: динамику кли нических показателей (глюкоза крови, гликозилированный гемоглобин, масса тела) и состояние ОВП в тканях организма по уровню активности НАДН, ФАД и показателю окислительного метаболизма (ПОМ) с помощью аппарата «Лазма-СТ». В течение того же срока исследовали состояние клеток крови (эритроциты, лейкоциты, тромбоциты) и костного мозга. Ста тистическую обработку результатов проводили с предварительным использованием теста Шапиро–Уилкса; достоверность различий с контролем оценивали с помощью параметрического t – критерия Стьюдента, при р<0,05. Результаты. В развитии СД2 выявлено 3 стадии прогрессирующего нарушения метаболизма и ОВП: I – стадия адаптации (1,0-2,0 мес); II – стадия прогрессирующей дисадаптации (2,5-4,5 мес); III – стадия декомпенсации (5,0-6,5 мес). Установлено, что уже в I стадии у мышей db/db снижалось содержание эритроцитов, Hb г/л и лейкоцитов. Во II и особенно в III стадиях происходило повышение тромбоцитов, нейтрофилов, моноцитов, эозинофилов, снижение лимфоцитов. В костном мозге у мышей db/db уже в I, но особенно в III стадии определялось снижение доли живых и повышение количества поврежден ных клеток, преимущественно за счёт апонекротических клеток. Заключение. По мере прогрессирования СД2 и выраженного снижения эффективности ОВП, особенно на III стадии – в организме тормозятся процессы кроветворения и усиливаются нарушения в соотношении клеточных популяций нейтро филы/лимфоциты, что свидетельствует о развитии тяжёлой гипоксии, активации системной воспалительной реакции и торможении репаративных процессов, создающих условия для развития опасных осложнений. Aim: to study the dynamics of changes in the blood and bone marrow cells during the progression of type 2 diabetes mellitus (DM2) depending on the severity of redox (RO) disorders in tissues. Methods. A genetic model of DM2 in mutant db/db mice (experimental group, n=30) was used. The control group consisted of the same mouse strain, db/+m (n=10), and the B10 strain (n=5). Time-related changes in clinical variables (blood glucose, HbA1c, body weight) and the tissue RO status were monitored for 6-6.5 months. The RO status was evaluated by the NADH concentration, FAD activ ity, and the indicator of oxidative metabolism (IOM) using a Lasma-ST apparatus. During the same period, the condition of blood cells (erythrocytes, leukocytes, platelets) and bone marrow cells was examined. Statistical analysis was performed with a preliminary Shap iro-Wilks normality test followed by the parametric Student’s t-test. Differences from the control were considered significant at p<0.05. Results. During the development of DM2, three stages of progressive metabolic and RO disorders were identified: I: stage of adap tation (1.0-2.0 months); II, stage of progressive maladaptation (2.5-4.5 months); III, stage of decompensation (5.0-6.5 months). In db/db mice already at stage I, erythrocytes, Hb and leukocytes were decreased. At stages II and especially III, platelets, neutrophils, monocytes, and eosinophils were increased whereas lymphocytes were reduced. In the bone marrow of db/db mice, already in stage I, but even more in stage III, the proportion of living cells was decreased and the proportion of damaged cells was increased, primarily due to the contribution of aponecrotic cells. Conclusion. With the progression of DM2 and a pronounced decrease in the effectiveness of RO processes, especially at stage III, the hematopoietic processes were inhibited and the disorders in the neutrophil/lymphocyte cell population ratio intensified. This indicates the development of severe hypoxia, activation of a systemic inflammatory response, and inhibition of reparative processes that create conditions for development of dangerous complications.

Verified
Journal Article
Open access
PDF file
MSMurat Shagidulin
Murat Shagidulin
AVArtem Andreevich Venediktov
Artem Andreevich Venediktov
AGAleksey Grigoryev
Aleksey Grigoryev
МИМила Ибрагимова
Мила Ибрагимова
AAArtur Aktemirov
Artur Aktemirov
SGSergey Gautier
Sergey Gautier
Liver fibrosis is a severe but common disease without an easy-to-access option for efficient treatment. Mesenchymal stem cells (MSCs) of different origins have been tested for antifibrotic effects in vitro, in vivo, and in clinical studies over the two last decades, although the comparative efficiency of different subtypes remains not fully understood, especially for long-term survival. In this study, we aimed to compare the long-time persistence of favorable effects in male Wistar rats with liver fibrosis treated using MSCs derived from white adipose tissue (AdMSCs) and bone marrow (BMSCs). Liver fibrosis was induced by carbon tetrachloride. We studied the survival rate; oxidative index, assessed via laser Doppler flowmetry; hepatic markers in blood plasma—albumin, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase; the ratio of liver to body mass; histological parameters—the number of adipocytes, lymphocytes, siderophages, and Ki67+ cells; and the relative areas of connective tissue proper and reticular fibers. Extra mortality was only typical for fibrotic animals subjected to the sham treatment in the first two weeks. Up to Day 270 of this study, both MSC-treated groups showed barely any differences from animals undergoing the sham treatment in terms of the oxidative index and blood markers, although AdMSC-treated rats presented a more favorable histological pattern than BMSC-treated ones, considering the relative area of reticular fibers and the Ki67 cell count. This study suggests that AdMSC treatments may be more appropriate than BMSC treatments in animal liver fibrosis models, with the results showing better potential for liver tissue regeneration 9 months after treatment.

15 September 2017 in Genes & Cells
Verified
Journal Article
Closed access
PDF file
MSMurat Shagidulin
Murat Shagidulin
NON. A Onishchenko
N. A Onishchenko
NMN. P Mozheyko
N. P Mozheyko
ZGZ. Z Gonikova
Z. Z Gonikova
VSV. I Sevast'YAnov
V. I Sevast'YAnov
СИСевастьянов В. И
Севастьянов В. И
Vliyanie kletochnogo sostava bioinzhenernykh konstruktsiy pecheni na korrektsiyu i lechenie khronicheskoy pechenochnoy nedostatochnosti Влияние клеточного состава биоинженерных конструкций печени на коррекцию и лечение хронической печеночной недостаточности